Norges Bank Invests $42.61 Million in Perrigo Company plc $PRGO

Norges Bank acquired a new position in Perrigo Company plc (NYSE:PRGO) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 3,060,846 shares of the company’s stock, valued at approximately $42,607,000. Norges Bank owned approximately 2.22% of Perrigo as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Geneos Wealth Management Inc. boosted its position in shares of Perrigo by 439.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after buying an additional 786 shares in the last quarter. Kestra Investment Management LLC lifted its stake in Perrigo by 57.1% in the 2nd quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock valued at $47,000 after buying an additional 642 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Perrigo by 89.1% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,778 shares of the company’s stock valued at $38,000 after buying an additional 838 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock valued at $26,000 after buying an additional 1,014 shares in the last quarter. Finally, CWM LLC lifted its stake in Perrigo by 230.0% in the 4th quarter. CWM LLC now owns 2,191 shares of the company’s stock valued at $31,000 after buying an additional 1,527 shares in the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Perrigo Trading Up 7.1%

Shares of PRGO opened at $11.60 on Tuesday. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $28.43. The stock’s fifty day simple moving average is $11.12 and its 200 day simple moving average is $12.49. The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45. The firm has a market capitalization of $1.60 billion, a P/E ratio of -0.89, a price-to-earnings-growth ratio of 1.28 and a beta of 0.51.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.39 by $0.04. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The firm had revenue of $841.80 million for the quarter, compared to analyst estimates of $1.04 billion. During the same quarter last year, the firm posted $0.60 earnings per share. Perrigo’s revenue for the quarter was down 7.2% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities research analysts forecast that Perrigo Company plc will post 2.12 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th will be given a $0.29 dividend. The ex-dividend date of this dividend is Friday, May 29th. This represents a $1.16 annualized dividend and a yield of 10.0%. Perrigo’s dividend payout ratio (DPR) is -8.85%.

Analysts Set New Price Targets

A number of research analysts have issued reports on PRGO shares. Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings lowered shares of Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. Finally, Canaccord Genuity Group reduced their price target on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research note on Friday, February 27th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Perrigo currently has an average rating of “Hold” and an average target price of $19.33.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.